Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 May;202(5):329-35.
doi: 10.1192/bjp.bp.112.118307.

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies

Breno S Diniz  1 , Meryl A Butters, Steven M Albert, Mary Amanda Dew, Charles F Reynolds 3rd
Affiliations
Meta-Analysis

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies

Breno S Diniz et al. Br J Psychiatry. 2013 May.

Abstract

Background: Late-life depression may increase the risk of incident dementia, in particular of Alzheimer's disease and vascular dementia.

Aims: To conduct a systematic review and meta-analysis to evaluate the risk of incident all-cause dementia, Alzheimer's disease and vascular dementia in individuals with late-life depression in population-based prospective studies.

Method: A total of 23 studies were included in the meta-analysis. We used the generic inverse variance method with a random-effects model to calculate the pooled risk of dementia, Alzheimer's disease and vascular dementia in older adults with late-life depression.

Results: Late-life depression was associated with a significant risk of all-cause dementia (1.85, 95% CI 1.67-2.04, P<0.001), Alzheimer's disease (1.65, 95% CI 1.42-1.92, P<0.001) and vascular dementia (2.52, 95% CI 1.77-3.59, P<0.001). Subgroup analysis, based on five studies, showed that the risk of vascular dementia was significantly higher than for Alzheimer's disease (P = 0.03).

Conclusions: Late-life depression is associated with an increased risk for all-cause dementia, vascular dementia and Alzheimer's disease. The present results suggest that it will be valuable to design clinical trials to investigate the effect of late-life depression prevention on risk of dementia, in particular vascular dementia and Alzheimer's disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

In the past 3 years B.S.D. has received payment for lectures from Novartis and had travel/meeting expenses covered by Pfizer. M.A.B. received remuneration for neuropsychological assessment services on a fee-for-service basis, for clinical trials conducted by Northstar Neuroscience and Medtronic and from Fox Learning Systems for developing computerised neuropsychological tasks for an NIH-funded study. The following pharmaceutical companies provide pharmaceutical supplies for C.F.R.’s NIH-sponsored work: Bristol-Myers Squibb, Forrest Laboratories, Lilly and Pfizer.

Figures

Fig. 1
Fig. 1
Flow chart of the study search and selection for inclusion in the meta-analysis. a. No description of sample setting, of baseline diagnosis of depression or the outcome diagnosis of dementia/Alzheimer’s disease, risk measure not calculated or not reported.
Fig. 2
Fig. 2
Forest plot for the risk of all-cause dementia in participants with late-life depression.
Fig. 3
Fig. 3
Forest plot for the risk of incident Alzheimer’s disease in participants with late-life depression.
Fig. 4
Fig. 4
Forest plot for the risk of incident vascular dementia in participants with late-life depression.
See this image and copyright information in PMC

References

    1. Byers AL, Yaffe K, Covinsky KE, Friedman MB, Bruce ML. High occurrence of mood and anxiety disorders among older adults: the National Comorbidity Survey Replication. Arch Gen Psychiatry 2010; 67: 489–96 - PMC - PubMed
    1. Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000; 157: 1949–54 - PubMed
    1. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF, 3rd, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008; 10: 345–57 - PMC - PubMed
    1. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006; 63: 530–8 - PMC - PubMed
    1. Lenoir H, Dufouil C, Auriacombe S, Lacombe JM, Dartigues JF, Ritchie K, et al. Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis 2011; 26: 27–38 - PubMed

Publication types